董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bobbi Jo Brockmann | 女 | Vice President of Sales and Marketing and Director | 48 | 21.62万美元 | 未持股 | 2025-11-01 |
| Steven T. Rosgen | 男 | Director | 59 | 未披露 | 未持股 | 2025-11-01 |
| Gloria J. Basse | 女 | Director | 65 | 未披露 | 未持股 | 2025-11-01 |
| Bryan K. Gathagan | 男 | Director | 57 | 未披露 | 未持股 | 2025-11-01 |
| Olivier te Boekhorst | 男 | President, Chief Executive Officer and Director | 54 | 未披露 | 未持股 | 2025-11-01 |
| David S. Tomsche | 男 | Chairman | 68 | 3.20万美元 | 未持股 | 2025-11-01 |
| Paul R. Wainman | 男 | Director | 60 | 2.00万美元 | 未持股 | 2025-11-01 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bobbi Jo Brockmann | 女 | Vice President of Sales and Marketing and Director | 48 | 21.62万美元 | 未持股 | 2025-11-01 |
| Timothy C. Fiori | 男 | Chief Financial Officer | 46 | 未披露 | 未持股 | 2025-11-01 |
| Olivier te Boekhorst | 男 | President, Chief Executive Officer and Director | 54 | 未披露 | 未持股 | 2025-11-01 |
董事简历
中英对照 | 中文 | 英文- Bobbi Jo Brockmann
-
Bobbi Jo Brockmann，她于2015年2月被提拔为销售和营销副总裁。她于2010年1月加入公司，担任销售和营销董事。此前，她一直担任APC公司（动物健康和营养的功能蛋白质产品的开发商和营销商，位于爱荷华安克尼）的销售董事（2008年5月以来）、销售经理（从2004年2月到2008年4月）。此前，她曾担任其它销售和营销职务，任职于APC, W & G Marketing Company（位于爱荷华艾姆斯）、The Council for Agricultural Science and Technology（位于爱荷华艾姆斯）、Meyocks Group Advertising（爱荷华州西得梅因）。此前，她毕业于Iowa State University。
Bobbi Jo Brockmann,served as a Director of the Company from March 2017 to September 2017 and from January 2018 to the present. She was promoted to Vice President of Sales and Marketing in February 2015. She joined the Company as Director of Sales and Marketing in January 2010. Prior to that, she had been employed as Director of Sales since May 2008 and Sales Manager from February 2004 to April 2008 at APC, Inc. of Ankeny, Iowa, a developer and marketer of functional protein products for animal health and nutrition. Prior to that, she held other sales and marketing positions at APC, W & G Marketing Company, Inc. of Ames, Iowa, The Council for Agricultural Science and Technology of Ames, Iowa and Meyocks Group Advertising of West Des Moines, Iowa after graduating from Iowa State University. - Bobbi Jo Brockmann，她于2015年2月被提拔为销售和营销副总裁。她于2010年1月加入公司，担任销售和营销董事。此前，她一直担任APC公司（动物健康和营养的功能蛋白质产品的开发商和营销商，位于爱荷华安克尼）的销售董事（2008年5月以来）、销售经理（从2004年2月到2008年4月）。此前，她曾担任其它销售和营销职务，任职于APC, W & G Marketing Company（位于爱荷华艾姆斯）、The Council for Agricultural Science and Technology（位于爱荷华艾姆斯）、Meyocks Group Advertising（爱荷华州西得梅因）。此前，她毕业于Iowa State University。
- Bobbi Jo Brockmann,served as a Director of the Company from March 2017 to September 2017 and from January 2018 to the present. She was promoted to Vice President of Sales and Marketing in February 2015. She joined the Company as Director of Sales and Marketing in January 2010. Prior to that, she had been employed as Director of Sales since May 2008 and Sales Manager from February 2004 to April 2008 at APC, Inc. of Ankeny, Iowa, a developer and marketer of functional protein products for animal health and nutrition. Prior to that, she held other sales and marketing positions at APC, W & G Marketing Company, Inc. of Ames, Iowa, The Council for Agricultural Science and Technology of Ames, Iowa and Meyocks Group Advertising of West Des Moines, Iowa after graduating from Iowa State University.
- Steven T. Rosgen
-
Steven T. Rosgen，于2018年1月被任命为董事会成员，董事会审计委员会成员，自2018年4月1日起生效。他于2024年6月成为薪酬和股票期权委员会主席。他是Strategem Research Inc.的总裁，该公司成立于2005年。Strategem的使命是在推出新技术和振兴在市场上苦苦挣扎的品牌时捕捉并利用客户洞察力。Rosgen先生专门研究价值主张开发和定价策略。他曾与多个行业的全球品牌合作，包括多个农业部门（农业信息学、动物健康、生物技术、作物保护、肥料、设备、金融、谷物营销、牲畜生产、零售和种子技术）。在创立Strategem之前，Rosgen先生是Baker Lovick/BBDO广告公司Street Smart战略规划和研究协调员的高级合伙人。他拥有卡尔加里大学的商业学士学位。
Steven T. Rosgen,was appointed to the Board of Directors in January 2018 and the Audit Committee of the Board of Directors effective April 1, 2018. He became Chair of the Compensation and Stock Option Committee in June 2024. He is President of Strategem Research Inc., founded in 2005. Strategem's mission is to capture and leverage customer insights when launching new technologies and revitalizing brands that have struggled in the market. Mr. Rosgen specializes in value proposition development and pricing strategy. He has worked with global brands across a range of industries including multiple agricultural sectors (ag informatics, animal health, biotechnology, crop protection, fertilizer, equipment, finance, grain marketing, livestock production, retail and seed technology). Before founding Strategem, Mr. Rosgen was a senior partner with Street Smart Strategic Planning and Research Coordinator for Baker Lovick/BBDO Advertising. He holds a Bachelor of Commerce Degree from the University of Calgary. - Steven T. Rosgen，于2018年1月被任命为董事会成员，董事会审计委员会成员，自2018年4月1日起生效。他于2024年6月成为薪酬和股票期权委员会主席。他是Strategem Research Inc.的总裁，该公司成立于2005年。Strategem的使命是在推出新技术和振兴在市场上苦苦挣扎的品牌时捕捉并利用客户洞察力。Rosgen先生专门研究价值主张开发和定价策略。他曾与多个行业的全球品牌合作，包括多个农业部门（农业信息学、动物健康、生物技术、作物保护、肥料、设备、金融、谷物营销、牲畜生产、零售和种子技术）。在创立Strategem之前，Rosgen先生是Baker Lovick/BBDO广告公司Street Smart战略规划和研究协调员的高级合伙人。他拥有卡尔加里大学的商业学士学位。
- Steven T. Rosgen,was appointed to the Board of Directors in January 2018 and the Audit Committee of the Board of Directors effective April 1, 2018. He became Chair of the Compensation and Stock Option Committee in June 2024. He is President of Strategem Research Inc., founded in 2005. Strategem's mission is to capture and leverage customer insights when launching new technologies and revitalizing brands that have struggled in the market. Mr. Rosgen specializes in value proposition development and pricing strategy. He has worked with global brands across a range of industries including multiple agricultural sectors (ag informatics, animal health, biotechnology, crop protection, fertilizer, equipment, finance, grain marketing, livestock production, retail and seed technology). Before founding Strategem, Mr. Rosgen was a senior partner with Street Smart Strategic Planning and Research Coordinator for Baker Lovick/BBDO Advertising. He holds a Bachelor of Commerce Degree from the University of Calgary.
- Gloria J. Basse
-
Gloria J. Basse，于2020年股东年会和薪酬与股票期权委员会同时加入董事会。她于2024年6月加入提名委员会，担任主席。Basse女士从2017年至今一直担任Tonisity International的高级执行董事，该公司是一家动物营养公司，在爱尔兰、巴西和美国设有办事处。自2016年以来，Basse女士一直担任Context Network的高级助理，这是一家为农业、生物技术和食品公司提供服务的商业管理和战略咨询公司。1985年至2015年，她曾在硕腾公司（前身为辉瑞TERM1）担任多个职位，最近担任该公司美国猪肉业务副总裁。Basse女士毕业于威斯康星大学，在罗切斯特大学获得工商管理硕士学位。
Gloria J. Basse,joined the Board of Directors at the 2020 Annual Meeting of Stockholders and the Compensation and Stock Option Committee at the same time. She joined the Nominating Committee as its Chair in June 2024. Ms. Basse has been the senior executive director of Tonisity International, an animal nutrition company with offices in Ireland, Brazil and the United States, from 2017 to the present. Since 2016, Ms. Basse has been a Senior Associate at the Context Network, a business management and strategy consulting firm providing services to agriculture, biotechnology and food companies. She held various positions at Zoetis Inc. (formerly Pfizer Animal Health) from 1985 to 2015 and most recently served as Vice President of its U.S. pork business. Ms. Basse is a graduate of the University of Wisconsin and earned her Masters in Business Administration from the University of Rochester. - Gloria J. Basse，于2020年股东年会和薪酬与股票期权委员会同时加入董事会。她于2024年6月加入提名委员会，担任主席。Basse女士从2017年至今一直担任Tonisity International的高级执行董事，该公司是一家动物营养公司，在爱尔兰、巴西和美国设有办事处。自2016年以来，Basse女士一直担任Context Network的高级助理，这是一家为农业、生物技术和食品公司提供服务的商业管理和战略咨询公司。1985年至2015年，她曾在硕腾公司（前身为辉瑞TERM1）担任多个职位，最近担任该公司美国猪肉业务副总裁。Basse女士毕业于威斯康星大学，在罗切斯特大学获得工商管理硕士学位。
- Gloria J. Basse,joined the Board of Directors at the 2020 Annual Meeting of Stockholders and the Compensation and Stock Option Committee at the same time. She joined the Nominating Committee as its Chair in June 2024. Ms. Basse has been the senior executive director of Tonisity International, an animal nutrition company with offices in Ireland, Brazil and the United States, from 2017 to the present. Since 2016, Ms. Basse has been a Senior Associate at the Context Network, a business management and strategy consulting firm providing services to agriculture, biotechnology and food companies. She held various positions at Zoetis Inc. (formerly Pfizer Animal Health) from 1985 to 2015 and most recently served as Vice President of its U.S. pork business. Ms. Basse is a graduate of the University of Wisconsin and earned her Masters in Business Administration from the University of Rochester.
- Bryan K. Gathagan
-
Bryan K. Gathagan，于2023年6月加入董事会，同时加入审计委员会。他于2024年6月加入提名委员会。他是Animalytix LLC的创始成员，自2010年开始运营以来一直担任其首席财务和首席技术官，拥有超过25年的动物保健行业经验。他还是管理咨询公司broad Thinking，LLC的所有者和管理成员。在加入Animalytix和Broad Thinking之前，他是Intervet，Inc.的高级主管兼IT和财务副总裁，并在1998年至2008年期间监督各种财务、IT和一般业务职能，其中包括在荷兰担任3年的全球职务。在进入动物保健行业之前，他曾在MBNA和Norwest Bank担任副总裁，负责各种IT职能，并在巴尔的摩县马里兰大学（UMBC）开始了他的IT角色生涯。他拥有UMBC信息系统管理学士学位和约翰霍普金斯大学商学硕士学位。
Bryan K. Gathagan,joined the Board of Directors in June 2023 and the Audit Committee at the same time. He joined the Nominating Committee in June 2024. He is a founding member of Animalytix LLC serving as its Chief Financial and Chief Technology Officer since it began operations in 2010 and has over 25 years of animal health industry experience. He is also the owner and managing member of broad Thinking, LLC, a management consulting firm. Prior to Animalytix and broad Thinking, he was a senior executive and Vice President of IT and Finance for Intervet, Inc. and oversaw various finance, IT and general business functions from 1998 to 2008, including 3 years in a global role based in The Netherlands. Before entering the animal health industry, he served as a Vice President at MBNA and Norwest Bank responsible for various IT functions and started his career in IT roles at the University of Maryland, Baltimore County (UMBC). He holds a BS in Information Systems Management from UMBC and an MS in Business from Johns Hopkins University. - Bryan K. Gathagan，于2023年6月加入董事会，同时加入审计委员会。他于2024年6月加入提名委员会。他是Animalytix LLC的创始成员，自2010年开始运营以来一直担任其首席财务和首席技术官，拥有超过25年的动物保健行业经验。他还是管理咨询公司broad Thinking，LLC的所有者和管理成员。在加入Animalytix和Broad Thinking之前，他是Intervet，Inc.的高级主管兼IT和财务副总裁，并在1998年至2008年期间监督各种财务、IT和一般业务职能，其中包括在荷兰担任3年的全球职务。在进入动物保健行业之前，他曾在MBNA和Norwest Bank担任副总裁，负责各种IT职能，并在巴尔的摩县马里兰大学（UMBC）开始了他的IT角色生涯。他拥有UMBC信息系统管理学士学位和约翰霍普金斯大学商学硕士学位。
- Bryan K. Gathagan,joined the Board of Directors in June 2023 and the Audit Committee at the same time. He joined the Nominating Committee in June 2024. He is a founding member of Animalytix LLC serving as its Chief Financial and Chief Technology Officer since it began operations in 2010 and has over 25 years of animal health industry experience. He is also the owner and managing member of broad Thinking, LLC, a management consulting firm. Prior to Animalytix and broad Thinking, he was a senior executive and Vice President of IT and Finance for Intervet, Inc. and oversaw various finance, IT and general business functions from 1998 to 2008, including 3 years in a global role based in The Netherlands. Before entering the animal health industry, he served as a Vice President at MBNA and Norwest Bank responsible for various IT functions and started his career in IT roles at the University of Maryland, Baltimore County (UMBC). He holds a BS in Information Systems Management from UMBC and an MS in Business from Johns Hopkins University.
- Olivier te Boekhorst
-
Olivier te Boekhorst，目前是Archimed的运营合伙人，Archimed是一家位于美国纽约市和法国里昂的全球投资公司。自2024年8月以来，他一直担任位于宾夕法尼亚州匹兹堡的实验室服务提供商SeqCenter的主席。从2004年到2022年，他在位于缅因州威斯布鲁克（纳斯达克：IDXX）的领先诊断产品和服务公司爱德士担任过几个不同的职位。最近，他担任IDEXX高级副总裁兼总经理，在2019年至2022年期间负责一系列业务，包括牲畜诊断、乳制品抗生素残留检测、水安全检测以及OPTI Medical人体即时护理和COVID检测。从1997年到2004年，te Boekhorst先生是波士顿咨询公司的项目负责人和战略顾问。
Olivier te Boekhorst,is currently an Operating Partner of Archimed, a global investment firm based in New York City and Lyon, France. He has served since August 2024 as Chair of SeqCenter, a laboratory services provider located in Pittsburgh, PA. From 2004 to 2022, he held several different positions at IDEXX Laboratories, a leading diagnostics products and services company, located in Westbrook, Maine (Nasdaq: IDXX). Most recently, he was Senior Vice President and General Manager for IDEXX, responsible for a portfolio of businesses including livestock diagnostics, dairy antibiotic residue testing, water safety testing, and OPTI Medical human point-of-care and COVID testing from 2019 to 2022. From 1997 to 2004, Mr. te Boekhorst was a Project Leader and Strategy Consultant for the Boston Consulting Group. - Olivier te Boekhorst，目前是Archimed的运营合伙人，Archimed是一家位于美国纽约市和法国里昂的全球投资公司。自2024年8月以来，他一直担任位于宾夕法尼亚州匹兹堡的实验室服务提供商SeqCenter的主席。从2004年到2022年，他在位于缅因州威斯布鲁克（纳斯达克：IDXX）的领先诊断产品和服务公司爱德士担任过几个不同的职位。最近，他担任IDEXX高级副总裁兼总经理，在2019年至2022年期间负责一系列业务，包括牲畜诊断、乳制品抗生素残留检测、水安全检测以及OPTI Medical人体即时护理和COVID检测。从1997年到2004年，te Boekhorst先生是波士顿咨询公司的项目负责人和战略顾问。
- Olivier te Boekhorst,is currently an Operating Partner of Archimed, a global investment firm based in New York City and Lyon, France. He has served since August 2024 as Chair of SeqCenter, a laboratory services provider located in Pittsburgh, PA. From 2004 to 2022, he held several different positions at IDEXX Laboratories, a leading diagnostics products and services company, located in Westbrook, Maine (Nasdaq: IDXX). Most recently, he was Senior Vice President and General Manager for IDEXX, responsible for a portfolio of businesses including livestock diagnostics, dairy antibiotic residue testing, water safety testing, and OPTI Medical human point-of-care and COVID testing from 2019 to 2022. From 1997 to 2004, Mr. te Boekhorst was a Project Leader and Strategy Consultant for the Boston Consulting Group.
- David S. Tomsche
-
David S. Tomsche, D.V.M，于2013年2月被任命为Immucell Corporation董事会主席和董事会提名委员会成员。他于2014年2月25日至2014年3月31日担任审计委员会成员。他是一名大型动物兽医，并是Leedstone Inc.公司（即原Stearns Veterinary Outlet, Inc.公司，一家动物健康业务和挤奶系统安装公司）和J-t of Melrose, Inc.（一家日本出口公司）的所有人。他于1995年担任一家动物健康产品经销商VetPharm, Inc.公司的董事，直至该公司于2007年被出售。他还是乳制品生产商。他在明尼苏达大学（University of Minnesota）获得学位。
David S. Tomsche,was appointed to serve as Chair of the Board of Directors in February 2013. He served on the Nominating Committee of the Board of Directors until September 2017. He served on the Audit Committee from February 2014 through March 2014 and from June 2021 through June 2024. He is a large animal veterinarian and owner of Leedstone Inc. (formerly Stearns Veterinary Outlet, Inc., an animal health distribution and milking system installation company) and of J-t Enterprises of Melrose, Inc., an exporter of ImmuCell products. He also is a dairy producer. He obtained his degrees from the University of Minnesota. - David S. Tomsche, D.V.M，于2013年2月被任命为Immucell Corporation董事会主席和董事会提名委员会成员。他于2014年2月25日至2014年3月31日担任审计委员会成员。他是一名大型动物兽医，并是Leedstone Inc.公司（即原Stearns Veterinary Outlet, Inc.公司，一家动物健康业务和挤奶系统安装公司）和J-t of Melrose, Inc.（一家日本出口公司）的所有人。他于1995年担任一家动物健康产品经销商VetPharm, Inc.公司的董事，直至该公司于2007年被出售。他还是乳制品生产商。他在明尼苏达大学（University of Minnesota）获得学位。
- David S. Tomsche,was appointed to serve as Chair of the Board of Directors in February 2013. He served on the Nominating Committee of the Board of Directors until September 2017. He served on the Audit Committee from February 2014 through March 2014 and from June 2021 through June 2024. He is a large animal veterinarian and owner of Leedstone Inc. (formerly Stearns Veterinary Outlet, Inc., an animal health distribution and milking system installation company) and of J-t Enterprises of Melrose, Inc., an exporter of ImmuCell products. He also is a dairy producer. He obtained his degrees from the University of Minnesota.
- Paul R. Wainman
-
Paul R. Wainman，他于2014年3月31日被任命为董事会成员，并是审计委员会成员。他因有会计和财务的背景而有资格担任财务专家。他于2013年9月担任Kleinfeld Paper of Billerica, MA总裁。2013年期间，他在多家纸张和贺卡行业公司担任顾问。2005年至2012年，他担任一家位于Kennebunk, ME的William Arthur, Inc.公司的总裁和CEO，该公司是Hallmark Cards的一个部门，他负责监管一个生产高端信纸的、拥有275名雇员的制造厂。在此之前，他于1998年至2004年担任Hallmark Cards公司另一部门的首席财务官。他是United Way of York County财务委员会一员，并是Kennebunks and Arundel教育基金董事会成员。他在英格兰谢菲尔德城市大学（Sheffield City University in England）获得会计和金融控制学位，并于1990年获得英格兰和威尔士注册会计师资格。
Paul R. Wainman,was appointed to the Board of Directors on March 31, 2014 and is a member of the Audit and Nominating Committees and serves as Chair of the Audit Committee. He qualifies to serve as a "financial expert" given his background in accounting and finance. Mr. Wainman served as Chief Financial Officer of Hancock Lumber, a 725-employee lumber and building products company located in Casco, Maine, from February 2016 and its President and CFO from January 2020 until, most recently, becoming President and CEO in January 2023. From April 2015 until February 2016, he was a business strategy and financial consultant specializing in the paper and greeting card industry. Prior to that, he was President of Kleinfeld, a personalized wedding stationery company, from September 2013 until April 2015. From 2005 to 2012, he was President and CEO of William Arthur, Inc., a division of Hallmark Cards, where he led a 275-employee manufacturer of luxury stationery products. Prior to that, he served another division of Hallmark Cards as CFO and COO from 1998 to 2004. He obtained a degree in Accounting and Financial Control from Sheffield City University in England and qualified as a Chartered Accountant of England and Wales in 1990. - Paul R. Wainman，他于2014年3月31日被任命为董事会成员，并是审计委员会成员。他因有会计和财务的背景而有资格担任财务专家。他于2013年9月担任Kleinfeld Paper of Billerica, MA总裁。2013年期间，他在多家纸张和贺卡行业公司担任顾问。2005年至2012年，他担任一家位于Kennebunk, ME的William Arthur, Inc.公司的总裁和CEO，该公司是Hallmark Cards的一个部门，他负责监管一个生产高端信纸的、拥有275名雇员的制造厂。在此之前，他于1998年至2004年担任Hallmark Cards公司另一部门的首席财务官。他是United Way of York County财务委员会一员，并是Kennebunks and Arundel教育基金董事会成员。他在英格兰谢菲尔德城市大学（Sheffield City University in England）获得会计和金融控制学位，并于1990年获得英格兰和威尔士注册会计师资格。
- Paul R. Wainman,was appointed to the Board of Directors on March 31, 2014 and is a member of the Audit and Nominating Committees and serves as Chair of the Audit Committee. He qualifies to serve as a "financial expert" given his background in accounting and finance. Mr. Wainman served as Chief Financial Officer of Hancock Lumber, a 725-employee lumber and building products company located in Casco, Maine, from February 2016 and its President and CFO from January 2020 until, most recently, becoming President and CEO in January 2023. From April 2015 until February 2016, he was a business strategy and financial consultant specializing in the paper and greeting card industry. Prior to that, he was President of Kleinfeld, a personalized wedding stationery company, from September 2013 until April 2015. From 2005 to 2012, he was President and CEO of William Arthur, Inc., a division of Hallmark Cards, where he led a 275-employee manufacturer of luxury stationery products. Prior to that, he served another division of Hallmark Cards as CFO and COO from 1998 to 2004. He obtained a degree in Accounting and Financial Control from Sheffield City University in England and qualified as a Chartered Accountant of England and Wales in 1990.
高管简历
中英对照 | 中文 | 英文- Bobbi Jo Brockmann
Bobbi Jo Brockmann，她于2015年2月被提拔为销售和营销副总裁。她于2010年1月加入公司，担任销售和营销董事。此前，她一直担任APC公司（动物健康和营养的功能蛋白质产品的开发商和营销商，位于爱荷华安克尼）的销售董事（2008年5月以来）、销售经理（从2004年2月到2008年4月）。此前，她曾担任其它销售和营销职务，任职于APC, W & G Marketing Company（位于爱荷华艾姆斯）、The Council for Agricultural Science and Technology（位于爱荷华艾姆斯）、Meyocks Group Advertising（爱荷华州西得梅因）。此前，她毕业于Iowa State University。
Bobbi Jo Brockmann,served as a Director of the Company from March 2017 to September 2017 and from January 2018 to the present. She was promoted to Vice President of Sales and Marketing in February 2015. She joined the Company as Director of Sales and Marketing in January 2010. Prior to that, she had been employed as Director of Sales since May 2008 and Sales Manager from February 2004 to April 2008 at APC, Inc. of Ankeny, Iowa, a developer and marketer of functional protein products for animal health and nutrition. Prior to that, she held other sales and marketing positions at APC, W & G Marketing Company, Inc. of Ames, Iowa, The Council for Agricultural Science and Technology of Ames, Iowa and Meyocks Group Advertising of West Des Moines, Iowa after graduating from Iowa State University.- Bobbi Jo Brockmann，她于2015年2月被提拔为销售和营销副总裁。她于2010年1月加入公司，担任销售和营销董事。此前，她一直担任APC公司（动物健康和营养的功能蛋白质产品的开发商和营销商，位于爱荷华安克尼）的销售董事（2008年5月以来）、销售经理（从2004年2月到2008年4月）。此前，她曾担任其它销售和营销职务，任职于APC, W & G Marketing Company（位于爱荷华艾姆斯）、The Council for Agricultural Science and Technology（位于爱荷华艾姆斯）、Meyocks Group Advertising（爱荷华州西得梅因）。此前，她毕业于Iowa State University。
- Bobbi Jo Brockmann,served as a Director of the Company from March 2017 to September 2017 and from January 2018 to the present. She was promoted to Vice President of Sales and Marketing in February 2015. She joined the Company as Director of Sales and Marketing in January 2010. Prior to that, she had been employed as Director of Sales since May 2008 and Sales Manager from February 2004 to April 2008 at APC, Inc. of Ankeny, Iowa, a developer and marketer of functional protein products for animal health and nutrition. Prior to that, she held other sales and marketing positions at APC, W & G Marketing Company, Inc. of Ames, Iowa, The Council for Agricultural Science and Technology of Ames, Iowa and Meyocks Group Advertising of West Des Moines, Iowa after graduating from Iowa State University.
- Timothy C. Fiori
Timothy C. Fiori，被选举为首席财务官，自2025年4月7日起生效。在过去的24年里，Fiori先生曾在缅因州威斯布鲁克的Idexx Laboratories担任过多个财务和商业运营职位，最近一次是自2020年起担任其商业运营财务高级总监。他于2001年以优异的成绩毕业于奥罗诺州缅因大学，获得金融学理学学士学位。
Timothy C. Fiori,was elected to serve as Chief Financial Officer effective April 7, 2025. For the past 24 years, Mr. Fiori has held various financial and commercial operating positions at Idexx Laboratories in Westbrook, Maine, most recently as its Senior Director of Finance, Commercial Operations since 2020. He graduated with honors from the University of Maine, Orono with a Bachelor of Science degree in Finance in 2001.- Timothy C. Fiori，被选举为首席财务官，自2025年4月7日起生效。在过去的24年里，Fiori先生曾在缅因州威斯布鲁克的Idexx Laboratories担任过多个财务和商业运营职位，最近一次是自2020年起担任其商业运营财务高级总监。他于2001年以优异的成绩毕业于奥罗诺州缅因大学，获得金融学理学学士学位。
- Timothy C. Fiori,was elected to serve as Chief Financial Officer effective April 7, 2025. For the past 24 years, Mr. Fiori has held various financial and commercial operating positions at Idexx Laboratories in Westbrook, Maine, most recently as its Senior Director of Finance, Commercial Operations since 2020. He graduated with honors from the University of Maine, Orono with a Bachelor of Science degree in Finance in 2001.
- Olivier te Boekhorst
Olivier te Boekhorst，目前是Archimed的运营合伙人，Archimed是一家位于美国纽约市和法国里昂的全球投资公司。自2024年8月以来，他一直担任位于宾夕法尼亚州匹兹堡的实验室服务提供商SeqCenter的主席。从2004年到2022年，他在位于缅因州威斯布鲁克（纳斯达克：IDXX）的领先诊断产品和服务公司爱德士担任过几个不同的职位。最近，他担任IDEXX高级副总裁兼总经理，在2019年至2022年期间负责一系列业务，包括牲畜诊断、乳制品抗生素残留检测、水安全检测以及OPTI Medical人体即时护理和COVID检测。从1997年到2004年，te Boekhorst先生是波士顿咨询公司的项目负责人和战略顾问。
Olivier te Boekhorst,is currently an Operating Partner of Archimed, a global investment firm based in New York City and Lyon, France. He has served since August 2024 as Chair of SeqCenter, a laboratory services provider located in Pittsburgh, PA. From 2004 to 2022, he held several different positions at IDEXX Laboratories, a leading diagnostics products and services company, located in Westbrook, Maine (Nasdaq: IDXX). Most recently, he was Senior Vice President and General Manager for IDEXX, responsible for a portfolio of businesses including livestock diagnostics, dairy antibiotic residue testing, water safety testing, and OPTI Medical human point-of-care and COVID testing from 2019 to 2022. From 1997 to 2004, Mr. te Boekhorst was a Project Leader and Strategy Consultant for the Boston Consulting Group.- Olivier te Boekhorst，目前是Archimed的运营合伙人，Archimed是一家位于美国纽约市和法国里昂的全球投资公司。自2024年8月以来，他一直担任位于宾夕法尼亚州匹兹堡的实验室服务提供商SeqCenter的主席。从2004年到2022年，他在位于缅因州威斯布鲁克（纳斯达克：IDXX）的领先诊断产品和服务公司爱德士担任过几个不同的职位。最近，他担任IDEXX高级副总裁兼总经理，在2019年至2022年期间负责一系列业务，包括牲畜诊断、乳制品抗生素残留检测、水安全检测以及OPTI Medical人体即时护理和COVID检测。从1997年到2004年，te Boekhorst先生是波士顿咨询公司的项目负责人和战略顾问。
- Olivier te Boekhorst,is currently an Operating Partner of Archimed, a global investment firm based in New York City and Lyon, France. He has served since August 2024 as Chair of SeqCenter, a laboratory services provider located in Pittsburgh, PA. From 2004 to 2022, he held several different positions at IDEXX Laboratories, a leading diagnostics products and services company, located in Westbrook, Maine (Nasdaq: IDXX). Most recently, he was Senior Vice President and General Manager for IDEXX, responsible for a portfolio of businesses including livestock diagnostics, dairy antibiotic residue testing, water safety testing, and OPTI Medical human point-of-care and COVID testing from 2019 to 2022. From 1997 to 2004, Mr. te Boekhorst was a Project Leader and Strategy Consultant for the Boston Consulting Group.